These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2537557)

  • 41. The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus.
    Broughton Pipkin F; Wallace CP
    Br J Pharmacol; 1986 Mar; 87(3):533-42. PubMed ID: 3026539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Brunner-Ferber F; Brunner HR; Biollaz J
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):408-17. PubMed ID: 9514186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The bladder angiotensin system in female rats: response to infusions of angiotensin I and the angiotensin converting enzyme inhibitor enalaprilat.
    Weaver-Osterholtz D; Reams G; De Vergel CF; Bauer JH
    J Urol; 2001 May; 165(5):1735-8. PubMed ID: 11342966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension].
    Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV
    Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intrarenal angiotensin converting enzyme inhibition in spontaneously hypertensive rats.
    Aihara H; Ogawa H; Kasuya A; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
    Eur J Pharmacol; 1999 May; 373(1):35-40. PubMed ID: 10408249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
    Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
    Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
    Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal actions of the new angiotensin-converting enzyme inhibitor benazepril hydrochloride.
    Levens NR
    Arch Int Pharmacodyn Ther; 1988; 296():131-43. PubMed ID: 2853611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
    Essig J; Belz GG; Wellstein A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating angiotensin II levels under repeated administration of lisinopril in normal subjects.
    Kawamura M; Imanashi M; Matsushima Y; Ito K; Hiramori K
    Clin Exp Pharmacol Physiol; 1992 Aug; 19(8):547-53. PubMed ID: 1326422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M; Guyene TT; Chatellier G; Ménard J
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
    Usalan C; Buyukhatipoglu H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: a prospective, placebo-controlled study in baboons (Papio hamadryas).
    Harewood WJ; Phippard AF; Duggin GG; Horvath JS; Tiller DJ
    Am J Obstet Gynecol; 1994 Sep; 171(3):633-42. PubMed ID: 8092208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute and chronic effects of a novel dihydrobenzofuran analogue and enalapril on blood pressure and plasma and tissue angiotensin converting enzyme activity in the sodium deficient normotensive rat.
    Longman SD; Howlett DR
    Arzneimittelforschung; 1988 May; 38(5):678-82. PubMed ID: 2843192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of ACE inhibitors on circulating versus cardiac angiotensin II in volume overload-induced cardiac hypertrophy in rats.
    Ruzicka M; Skarda V; Leenen FH
    Circulation; 1995 Dec; 92(12):3568-73. PubMed ID: 8521580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    Hypertension; 1986 Jun; 8(6):476-82. PubMed ID: 3011664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure.
    Grassi G; Cattaneo BM; Seravalle G; Lanfranchi A; Pozzi M; Morganti A; Carugo S; Mancia G
    Circulation; 1997 Aug; 96(4):1173-9. PubMed ID: 9286946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E631-7. PubMed ID: 8386457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.